T/R 90% to 110% for sample size estimation [Regulatives / Guidelines]

posted by kumarnaidu – Mumbai, India, 2013-11-26 06:36 (4585 d 17:40 ago) – Posting: # 11969
Views: 9,861

(edited on 2013-11-26 11:08)

Dear all,
If in my earlier studies I am getting T/R ratio= 110% means >5% difference then for planning another study for another market should I go with the T/R=110% or 95% for sample size estimation.

As per EMA guideline (2010) "batches should not differ more than 5%" so taking 10% difference in T/R ratio is considerable.

Also if I am taking the T/R ratio=110% I am getting sample size around 50 (without dropout) but many studies I found for this drug is around 40 even our earlier study had 42. then in that case if am exceeding sample size will it considered as a forced bioequivalence?

Earlier study results used for sample size estimation
LnCmax ratio=110.3 (90%CI- 101.06-120.54) CV=24.3.

Please reply.

Kumar Naidu

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
126 visitors (0 registered, 126 guests [including 14 identified bots]).
Forum time: 01:17 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5